India's perspective on Outsourcing

Marcel Velterop recently contributed a piece to PharmaTech.com looking at the Indian landscape of CROs and how they've improved and changed over the past 20 years. They've transformed from a low cost region to a location where high quality and compliance have transformed the clinical landscape. Aside from the US, there are now more FDA approved facilities than anywhere else in the world. Velterop looks at how his company, Dr Reddy's Custom Pharmaceutical Services, has taken on this landscape and adjusted to fit the new parameters the growing region is presenting.